A variety of chemotherapy combinations have been used, including cyclophosphamide + vincristine + dacarbazine (DTIC), which may produce tumor regression and improve symptoms, biochemical markers and hypertension.
Radiation therapy may improve or palliate local complications caused by metastases.
Five-Year Survival About 40 to 45 percent
Investigational
• Clinical trials are under way to find more effective chemotherapy treatments.
• One therapeutic approach for patients whose tumors cannot be removed, have recurred or have metastasized is targeted radiation therapy with I-131-MIBG. This treatment has resulted in the shrinkage of tumors and a reduction in symptoms in some patients.
